Scaffolds obtained from decellularized human extrahepatic bile ducts support organoids to establish functional biliary tissue in a dish. Issue 2 (9th November 2020)

• Record Type: Journal Article
• Authors: Willemse, Jorke; Roos, Floris J. M.; Voogt, Iris J.; Schurink, Ivo J.; Bijvelds, Marcel; de Jonge, Hugo R.; van der Laan, Luc J. W.; de Jonge, Jeroen; Verstegen, Monique M. A.
• Is Part Of: Biotechnology and bioengineering. Volume 118:Issue 2(2021)
• Page Start: 836
• Page End: 851
• Publication Date: 2020-11-09
• Subjects: personalized regenerative medicine -- LGR5+ organoids -- extrahepatic bile duct -- decellularization -- tissue engineering; Biotechnology -- Periodicals; Bioengineering -- Periodicals; 660.6
• DOI: 10.1002/bit.27613
• Languages: English
• ISSNs: 0006-3592

Abstract

Abstract: Biliary disorders can lead to life‐threatening disease and are also a challenging complication of liver transplantation. As there are limited treatment options, tissue engineered bile ducts could be employed to replace or repair damaged bile ducts. We explored how these constructs can be created by seeding hepatobiliary LGR5 + organoids onto tissue‐specific scaffold. For this, we decellularized discarded human extrahepatic bile ducts (EBD) that we recellularized with organoids of different origin, that is, liver biopsies, extrahepatic bile duct biopsies, and bile samples. Here, we demonstrate efficient decellularization of EBD tissue. Recellularization of the EBD extracellular matrix (ECM) with the organoids of extrahepatic origin (EBD tissue and bile derived organoids) showed more profound repopulation of the ductal ECM when compared with liver tissue (intrahepatic bile duct) derived organoids. The bile duct constructs that were repopulated with extrahepatic organoids expressed mature cholangiocyte‐markers and had increased electrical resistance, indicating restoration of the barrier function. Therefore, the organoids of extrahepatic sources are identified to be the optimal candidate for the development of personalized tissue engineered EBD constructs. Abstract : Willemse and coworkers successfully decellularized human extrahepatic bile duct tissue. Organoids from three different hepatobiliary sources (intrahepatic bile ducts, extrahepatic bile ducts, and bile) were tested for their repopulation efficiency on the decellularized ductal matrix. Bile‐ and extrahepatic bile duct‐derived organoids were capable of repopulating the ductal matrix, expressed cholangiocyte‐specific markers, and restored barrier function.